Page last updated: 2024-08-21

lactulose and Recrudescence

lactulose has been researched along with Recrudescence in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (12.50)	18.7374
1990's	5 (20.83)	18.2507
2000's	3 (12.50)	29.6817
2010's	10 (41.67)	24.3611
2020's	3 (12.50)	2.80

Authors

Authors	Studies
Abughosh, SM; Chen, H; Serna, O; Vadhariya, A; Zamil, H	1
Ahmad, M; Bozkaya, D; Jesudian, AB; Migliaccio-Walle, K	1
Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H	1
Baik, SK; Chang, Y; Cho, EJ; Cho, H; Cho, YY; Kang, SH; Kim, MY; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Yoo, JJ; Yoon, JH; Yu, SJ	1
Hudson, M; Schuchmann, M	1
Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Kamath, PS; Lai, J; Maliakkal, B; O'Leary, JG; Reddy, KR; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, PJ; Vargas, HE; Wong, F	1
Kamath, PS; Kim, WR; Leise, MD; Poterucha, JJ	1
Morillas, RM; Planas, R; Sala, M	1
Barreto, M; Campisano, M; Evangelisti, M; Lionetto, L; Negro, V; Principessa, L; Simmaco, M; Villa, MP	1
Chang, Q; Deng, Q; Meng, S; Pan, Y; Wang, L	1
Vogelsang, H	1
Shaikh, OS; Sundaram, V	1
Barritt, AS; Fried, MW; Hayashi, PH	1
Bajaj, JS; Bell, D; Gilles, H; Heuman, DM; Sanyal, AJ	1
Ahluwalia, V; Bajaj, JS; Bell, DE; Crossey, MM; Fatouros, PP; Gillevet, PM; Heuman, DM; Hylemon, PB; Kettenmann, B; Patel, NR; Ridlon, JM; Schubert, CM; Sikaroodi, M; Taylor-Robinson, SD	1
Hübl, W; Lochs, H; Vogelsang, H; Waldhöer, T; Wyatt, J	1
Nolte, W; Ramadori, G	1
Bour, AV; Manuk'ian, GV; Shertsinger, AG; Umruzakov, IU	1
Meddings, JB	1
Corrao, G; D'Incà, R; D'Odorico, A; Di Leo, V; Longo, G; Martines, D; Mestriner, C; Sturniolo, GC; Venturi, C	1
Arnott, ID; Ghosh, S; Kingstone, K	1
Kosman, ME	1
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Pieche, U; Pinto, G; Riggio, O; Tremiterra, S; Ziparo, V	1
Heredia, D; Orteu, N; Rodés, J; Terés, J	1

Reviews

6 review(s) available for lactulose and Recrudescence

Article	Year
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:4 Topics: Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Recurrence; Rifaximin; Secondary Prevention	2019
Management of hepatic encephalopathy in the hospital. Mayo Clinic proceedings, 2014, Volume: 89, Issue:2 Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Metronidazole; Neomycin; Protein Synthesis Inhibitors; Recurrence; Rifamycins; Rifaximin; Terminology as Topic	2014
[Prevention of hepatic encephalopathy]. Medicina clinica, 2014, Jun-06, Volume: 142, Issue:11 Topics: Anti-Bacterial Agents; Central Nervous System Depressants; Contraindications; Diuretics; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Absorption; Lactulose; Liver Cirrhosis; Liver Transplantation; Meta-Analysis as Topic; Peritonitis; Portasystemic Shunt, Surgical; Postoperative Complications; Recurrence; Rifamycins; Rifaximin; Risk Factors; Sugar Alcohols	2014
Hepatic encephalopathy: pathophysiology and emerging therapies. The Medical clinics of North America, 2009, Volume: 93, Issue:4 Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc	2009
[Therapy of hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 1996, May-24, Volume: 121, Issue:21 Topics: Acute Disease; Controlled Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Recurrence	1996
Review article: Intestinal permeability in Crohn's disease. Alimentary pharmacology & therapeutics, 1997, Volume: 11 Suppl 3 Topics: Animals; Crohn Disease; Disease Susceptibility; Epithelium; Humans; Intestinal Mucosa; Intestine, Small; Lactulose; Mannitol; Osmosis; Recurrence; Risk Factors; Sucrose	1997

Trials

3 trial(s) available for lactulose and Recrudescence

Article	Year
[Efficacy and safety of lactulose on the treatment of puerperal constipation]. Zhonghua yi xue za zhi, 2015, Jul-28, Volume: 95, Issue:28 Topics: Constipation; Defecation; Female; Hospitals; Humans; Lactulose; Postpartum Period; Pregnancy; Prenatal Care; Recurrence	2015
Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Digestive diseases and sciences, 1989, Volume: 34, Issue:6 Topics: Adolescent; Adult; Amino Acids; Clinical Trials as Topic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Random Allocation; Recurrence; Sugar Alcohols	1989
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. Journal of hepatology, 1988, Volume: 7, Issue:1 Topics: Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Neuropsychological Tests; Recurrence; Sugar Alcohols	1988

Other Studies

15 other study(ies) available for lactulose and Recrudescence

Article	Year
A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy. Medicine, 2020, Volume: 99, Issue:16 Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Drug Prescriptions; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Medicare Part C; Medication Adherence; Middle Aged; Neomycin; Patient Readmission; Recurrence; Retrospective Studies; Rifaximin; United States	2020
Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy. Journal of managed care & specialty pharmacy, 2020, Volume: 26, Issue:6 Topics: Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Hepatic Encephalopathy; Hospitalization; Humans; Incidence; Lactulose; Liver Cirrhosis; Liver Transplantation; Maintenance Chemotherapy; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Rifaximin; Secondary Prevention	2020
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:7 Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin	2020
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:9 Topics: Aged; Anti-Infective Agents; Bacterial Infections; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Peritonitis; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Secondary Prevention	2017
Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:12 Topics: Aged; Cohort Studies; Drug Therapy, Combination; End Stage Liver Disease; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Quality of Health Care; Recurrence; Rifaximin	2019
Intestinal permeability in children with recurrent respiratory and gastrointestinal symptoms. Journal of paediatrics and child health, 2015, Volume: 51, Issue:12 Topics: Adolescent; Asthma; Child; Child, Preschool; Female; Gastrointestinal Diseases; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Permeability; Recurrence; Skin Tests; Surveys and Questionnaires	2015
Do changes in intestinal permeability predict disease relapse in Crohn's disease? Inflammatory bowel diseases, 2008, Volume: 14 Suppl 2 Topics: Crohn Disease; Edetic Acid; Humans; Intestinal Mucosa; Lactulose; Molecular Weight; Permeability; Polyethylene Glycols; Predictive Value of Tests; Recurrence; Sucrose	2008
Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Digestive diseases and sciences, 2010, Volume: 55, Issue:6 Topics: Drug Therapy, Combination; Embolization, Therapeutic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Circulation; Liver Transplantation; Male; Middle Aged; Portal System; Portography; Recurrence; Rifamycins; Rifaximin; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler	2010
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Recurrence; Retrospective Studies; Young Adult	2010
A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metabolic brain disease, 2012, Volume: 27, Issue:2 Topics: Aged; Brain Chemistry; Cytokines; Feces; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Least-Squares Analysis; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Metabolomics; Metagenome; Middle Aged; Neuropsychological Tests; Recurrence; Systems Biology	2012
Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet (London, England), 1993, Jun-05, Volume: 341, Issue:8858 Topics: Adult; Crohn Disease; Female; Humans; Intestinal Mucosa; Lactulose; Male; Mannitol; Permeability; Predictive Value of Tests; Recurrence	1993
[Enteral detoxication in patients with liver cirrhosis and bleeding from the esophageal and gastric varices ]. Khirurgiia, 1997, Issue:2 Topics: Combined Modality Therapy; Embolization, Therapeutic; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastric Lavage; Gastrointestinal Agents; Humans; Lactulose; Liver Cirrhosis; Recurrence; Sorption Detoxification; Treatment Outcome; Urea	1997
Intestinal permeability test as a predictor of clinical course in Crohn's disease. The American journal of gastroenterology, 1999, Volume: 94, Issue:10 Topics: Adolescent; Adult; Aged; Biomarkers; Blood Sedimentation; C-Reactive Protein; Crohn Disease; Female; Humans; Intestinal Mucosa; Lactulose; Leukocyte Count; Male; Mannitol; Middle Aged; Orosomucoid; Permeability; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence	1999
Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Crohn Disease; Female; Humans; Intestines; Lactulose; Male; Middle Aged; Permeability; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Remission Induction; Rhamnose	2000
Lactulose (cephulac) in portosystemic encephalopathy. JAMA, 1976, Nov-22, Volume: 236, Issue:21 Topics: Ammonia; Depression, Chemical; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Recurrence	1976